Human Wnt inhibitory factor 1 (WIF1) ELISA Kit

Category: Assay Kits
Catalog
AE11193HU
(Ships in 5-10 business days)

Questions? Contact us

Call (800) 832-2611

arp-guarantee
- +
$0.00
More Information
Product Name Human Wnt inhibitory factor 1 (WIF1) ELISA Kit
Description WNT proteins are extracellular signaling molecules involved in the control of embryonic development. This gene encodes a secreted protein, which binds WNT proteins and inhibits their activities. This protein contains a WNT inhibitory factor (WIF) domain and 5 epidermal growth factor (EGF)-like domains. It may be involved in mesoderm segmentation. This protein is found to be present in fish, amphibia and mammals.The deduced 379-amino acid WIF1 secreted protein contains an N-terminal signal sequence, a 150-amino acid WIF domain, 5 epidermal growth factor (EGF)-like repeats that are similar to those of tenascin, and a C-terminal hydrophilic domain of approximately 45 amino acids. Overexpression of human WIF1 in frog embryos affected somitogenesis depending on the site and timing of WIF1 injection. . This assay has high sensitivity and excellent specificity for detection of Human WIF1. No significant cross-reactivity or interference between Human WIF1 and analogues was observed.
Synonyms WIF-1,
Method Sandwich ELISA
Detection Range 15.6-1000 pg/mL
Sensitivity 5.6 pg/mL
Reactivity Human
Sample Types Serum, Plasma, Other biological fluids.
Background WNT proteins are extracellular signaling molecules involved in the control of embryonic development. This gene encodes a secreted protein, which binds WNT proteins and inhibits their activities. This protein contains a WNT inhibitory factor (WIF) domain and 5 epidermal growth factor (EGF)-like domains. It may be involved in mesoderm segmentation. This protein is found to be present in fish, amphibia and mammals.The deduced 379-amino acid WIF1 secreted protein contains an N-terminal signal sequence, a 150-amino acid WIF domain, 5 epidermal growth factor (EGF)-like repeats that are similar to those of tenascin, and a C-terminal hydrophilic domain of approximately 45 amino acids. Overexpression of human WIF1 in frog embryos affected somitogenesis depending on the site and timing of WIF1 injection. .
Supplier Abebio

All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.